Table 1. Effects of PTPN22 SNPs on VKH syndrome risk.

Genotype	VKH		Controls		P value	Pc value	OR (95%CI)
	N = 1005		N = 2010
rs2488457	N	%	N	%
GG	102	10.1	310	15.4	7.06×10−5	6.35×10−4	0.62(0.49–0.79)
CG	454	45.2	1009	51.2	0.009	NS	0.82(0.70–0.95)
CC	449	44.7	691	34.4	3.86×10−8	3.47×10−7	1.54(1.32–1.80)
G Allele	658	32.7	1629	40.5	4.25×10−9	3.83×10−8	0.71(0.64–0.80)
C Allele	1352	67.3	2391	59.5	4.25×10−9	3.83×10−8	1.40(1.25–1.57)
rs1310182
CC	48	4.8	84	4.2	0.450	NS	1.15(0.80–1.65)
CT	292	29	589	29.3	0.887	NS	0.99(0.84–1.17)
TT	665	66.2	1337	66.5	0.849	NS	0.99(0.84–1.16)
C Allele	388	19.3	757	18.8	0.659	NS	1.03(0.90–1.18)
T Allele	1622	80.7	3263	81.2	0.659	NS	0.97(0.85–1.11)
rs3789604
TT	648	64.5	1254	62.4	0.262	NS	1.09(0.94–1.28)
GT	303	30.1	651	32.4	0.231	NS	0.90(0.77–1.06)
GG	54	5.4	105	5.2	0.863	NS	1.03(0.74–1.44)
T Allele	1599	79.6	3159	78.6	0.384	NS	1.06(0.96–1.21)
G Allele	411	20.4	861	21.4	0.384	NS	0.94(0.83–1.08)

P_c = Bonferroni corrected P value. NS = Not significant. OR = odds ratio. 95% CI = 95% confidence interval.